FPHAX: Fidelity® Select Pharmaceuticals Port

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Fixed income news, reports, video and more.

Municipal bonds news, reports, video and more.

Practice management news, reports, video and more.

Portfolio management news, reports, video and more.

Retirement news, reports, video and more.

Learn from industry thought leaders and expert market participants.

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

FPHAX Fidelity® Select Pharmaceuticals Port


Profile

FPHAX - Profile

Vitals

  • YTD Return 3.3%
  • 3 Yr Annualized Return 8.2%
  • 5 Yr Annualized Return 0.4%
  • Net Assets $894 M
  • Holdings in Top 10 65.3%

52 WEEK LOW AND HIGH

$24.09
$18.08
$24.46

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.78%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 52.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $0
  • IRA $2,500

Fund Classification


Distributions

  • YTD Total Return 3.3%
  • 3 Yr Annualized Total Return 8.9%
  • 5 Yr Annualized Total Return 2.6%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio 1.36%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Semi-Annually

Fund Details

  • Legal Name
    Fidelity® Select Pharmaceuticals Portfolio
  • Fund Family Name
    Fidelity Investments
  • Inception Date
    Jun 18, 2001
  • Shares Outstanding
    N/A
  • Share Class
    No Load
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Karim Suwwan de Felipe

Fund Description

The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.


Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.


Categories

Fund Company Quick Screens

FPHAX - Fund Company Quick Screens


Performance

FPHAX - Performance

Return Ranking - Trailing

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
YTD 3.3% -9.3% 18.0% 72.31%
1 Yr 14.5% -13.3% 28.0% 39.83%
3 Yr 8.2%* -13.9% 22.4% 25.23%
5 Yr 0.4%* -11.4% 11.3% 36.54%
10 Yr 8.4%* -1.3% 18.3% 55.95%

* Annualized

Return Ranking - Calendar

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
2019 21.0% 5.7% 55.4% 44.44%
2018 3.8% -25.3% 21.5% 3.60%
2017 8.9% -10.8% 43.9% 78.90%
2016 -17.2% -31.6% 6.9% 59.43%
2015 -3.8% -20.4% 13.8% 63.37%

Total Return Ranking - Trailing

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
YTD 3.3% -9.3% 18.0% 72.31%
1 Yr 14.5% -13.3% 28.0% 39.83%
3 Yr 8.9%* -13.9% 25.5% 27.93%
5 Yr 2.6%* -11.4% 15.6% 50.00%
10 Yr 13.5%* -1.3% 19.9% 44.05%

* Annualized

Total Return Ranking - Calendar

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
2019 21.0% 5.7% 55.4% 44.44%
2018 4.4% -25.3% 22.2% 4.50%
2017 10.7% -10.8% 45.8% 85.32%
2016 -16.3% -26.4% 8.7% 69.81%
2015 8.3% -16.6% 15.2% 27.72%

NAV & Total Return History


Holdings

FPHAX - Holdings

Concentration Analysis

FPHAX Category Low Category High FPHAX % Rank
Net Assets 894 M 2.35 M 47.5 B 57.46%
Number of Holdings 62 27 433 76.87%
Net Assets in Top 10 589 M 579 K 16.9 B 32.84%
Weighting of Top 10 65.25% 21.5% 76.0% 4.48%

Top 10 Holdings

  1. AstraZeneca PLC ADR 11.92%
  2. Sanofi SA ADR 9.09%
  3. Johnson & Johnson 7.74%
  4. Bristol-Myers Squibb Company 7.12%
  5. Roche Holding AG Dividend Right Cert. 6.71%
  6. Eli Lilly and Co 5.90%
  7. Merck & Co Inc 4.79%
  8. Novartis AG ADR 4.45%
  9. Zoetis Inc Class A 3.79%
  10. Amgen Inc 3.73%

Asset Allocation

Weighting Return Low Return High FPHAX % Rank
Stocks
96.46% 65.31% 100.26% 69.40%
Cash
3.25% -0.23% 34.69% 31.34%
Other
0.29% -1.50% 9.19% 30.60%
Preferred Stocks
0.00% 0.00% 4.57% 14.93%
Convertible Bonds
0.00% 0.00% 0.00% 2.24%
Bonds
0.00% 0.00% 16.54% 9.70%

Stock Sector Breakdown

Weighting Return Low Return High FPHAX % Rank
Healthcare
100.00% 60.00% 100.00% 1.49%
Utilities
0.00% 0.00% 0.00% 1.49%
Technology
0.00% 0.00% 15.32% 11.94%
Real Estate
0.00% 0.00% 5.63% 10.45%
Industrials
0.00% 0.00% 3.92% 5.22%
Financial Services
0.00% 0.00% 1.53% 32.09%
Energy
0.00% 0.00% 0.33% 2.24%
Communication Services
0.00% 0.00% 5.13% 5.22%
Consumer Defense
0.00% 0.00% 36.48% 10.45%
Consumer Cyclical
0.00% 0.00% 0.96% 15.67%
Basic Materials
0.00% 0.00% 2.53% 17.16%

Stock Geographic Breakdown

Weighting Return Low Return High FPHAX % Rank
US
52.09% 52.09% 99.18% 100.00%
Non US
44.37% 0.00% 44.37% 0.75%

Expenses

FPHAX - Expenses

Operational Fees

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.78% 0.10% 25.14% 85.38%
Management Fee 0.54% 0.00% 1.30% 5.97%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.40% N/A

Sales Fees

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% 70.73%

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 52.00% 0.70% 248.00% 71.54%

Distributions

FPHAX - Distributions

Dividend Yield Analysis

FPHAX Category Low Category High FPHAX % Rank
Dividend Yield 0.00% 0.00% 0.06% 5.97%

Dividend Distribution Analysis

FPHAX Category Low Category High Category Mod
Dividend Distribution Frequency Semi-Annually Annually Annually Annually

Net Income Ratio Analysis

FPHAX Category Low Category High FPHAX % Rank
Net Income Ratio 1.36% -2.53% 2.12% 1.54%

Capital Gain Distribution Analysis

FPHAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Semi-Annually Annually

Dividend Payout History

View More +

Fund Manager Analysis

FPHAX - Fund Manager Analysis

Managers

Karim Suwwan de Felipe


Start Date

Tenure

Tenure Rank

Jul 01, 2017

3.0

3.0%

Karim Suwwan de Felipe is portfolio manager of Pharmaceuticals Portfolio, which he has managed since July 2017. Since joining Fidelity Investments in 2010, Mr. Suwwan de Felipe has worked as a research analyst and portfolio manager

Tenure Analysis

Category Low Category High Category Average Category Mode
0.08 22.81 8.53 20.18